Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9 Rectal Neoplasms 3 Lymphatic Metastasis 3 Stomach Neoplasms 2 Prostatic Neoplasms 2 Uterine Cervical Neoplasms 1 Secondary Lymphedema 1 Neoplasm Micrometastasis 1 Melanoma 1 Liver Neoplasms 1 Inflammatory Bowel Diseases 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Erectile Dysfunction 1 Endometrial Neoplasms 1 Diverticular Diseases 1 Digestive System Diseases 1 Detection Rate of SLN ; Accuracy Rate of Lymph Node Metastasis 1 Colonic Neoplasms 1 Cervical Cancer Stage IB1 1 Carcinoma, Hepatocellular 1 Anastomotic Leak 1

Interventions

Sorafenib 9 Radiofrequency Ablation 7 Oxaliplatin 7 Fluorouracil 6 Doxorubicin 6 Neoadjuvant Therapy 5 toripalimab 4 lenvatinib 4 Injections 4 Chemotherapy, Adjuvant 4 Bevacizumab 4 sintilimab 3 pembrolizumab 3 Ultrasonography 3 Thalidomide 3 Leucovorin 3 Irinotecan 3 Cisplatin 3 tislelizumab 2 durvalumab 2 camrelizumab 2 anlotinib 2 Walking Speed 2 Standard of Care 2 Radiosurgery 2 Oncolytic Virotherapy 2 Metformin 2 Liver Transplantation 2 Laparoscopy 2 Immunohistochemistry 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Liver Neoplasms × Indocyanine Green × Clear all

NCT05160740 2022-02-04

ICGMFITinPLC

Zhujiang Hospital

Phase NA Unknown

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡